Literature DB >> 19760027

Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.

Konstantinos K Tsilidis1, Kathy J Helzlsouer, Michael W Smith, Victoriya Grinberg, Judith Hoffman-Bolton, Sandra L Clipp, Kala Visvanathan, Elizabeth A Platz.   

Abstract

OBJECTIVE AND METHODS: The association of 17 candidate single nucleotide polymorphisms (SNPs) in IL10 and other immune response genes (CRP, TLR4, IL6, IL1B, IL8, TNF, RNASEL) and genes related to obesity (PPARG, TCF7L2, ADIPOQ, LEP) with colorectal cancer was investigated. Haplotype tagging SNPs were chosen for IL10, CRP, and TLR4. Incident colorectal cancer cases (n = 208) and matched controls (n = 381) were identified between baseline in 1989 and 2003 among participants in the CLUE II cohort. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using conditional logistic regression.
RESULTS: Compared with the AA genotype at the candidate IL10-1082 locus (rs1800896), carrying one (OR, 0.79; 95% CI, 0.53-1.18) or two (OR, 0.58; 95% CI, 0.35-0.95) G alleles, a known higher producer of the anti-inflammatory cytokine IL-10, was associated with lower risk of colorectal cancer (p trend = 0.03). Statistically significant associations with colorectal cancer were observed for three tagSNPs in IL10 (rs1800890, rs3024496, rs3024498) and one common haplotype, but these associations were due to high linkage disequilibrium with IL10-1082. Two CRP haplotypes (global p = 0.04) and TLR4 tagSNPs (rs7873784, rs11536891), but not TLR4 haplotypes, were associated with colorectal cancer.
CONCLUSIONS: Our study suggests that polymorphisms in IL10, and also possibly in CRP and other genes related to immune response or obesity may be associated with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760027      PMCID: PMC4119174          DOI: 10.1007/s10552-009-9427-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  68 in total

1.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

2.  A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.

Authors:  Esther K Wei; Jing Ma; Michael N Pollak; Nader Rifai; Charles S Fuchs; Susan E Hankinson; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

3.  Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.

Authors:  Sayaka Otake; Hiroaki Takeda; Yasukuni Suzuki; Tadahisa Fukui; Shinichiro Watanabe; Katsuyoshi Ishihama; Takafumi Saito; Hitoshi Togashi; Tadashi Nakamura; Yuji Matsuzawa; Sumio Kawata
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

Review 4.  Beta-catenin--a linchpin in colorectal carcinogenesis?

Authors:  Newton Alexander Chiang Shuek Wong; Massimo Pignatelli
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

5.  Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development.

Authors:  S Sturlan; G Oberhuber; B G Beinhauer; B Tichy; S Kappel; J Wang; M A Rogy
Journal:  Carcinogenesis       Date:  2001-04       Impact factor: 4.944

6.  Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.

Authors:  Virginia G Kaklamani; Kari B Wisinski; Maureen Sadim; Cassandra Gulden; Albert Do; Kenneth Offit; John A Baron; Habibul Ahsan; Christos Mantzoros; Boris Pasche
Journal:  JAMA       Date:  2008-10-01       Impact factor: 56.272

7.  Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.

Authors:  Aditi Hazra; Charles S Fuchs; Andrew T Chan; Edward L Giovannucci; David J Hunter
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

Review 8.  C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.

Authors:  Konstantinos K Tsilidis; Casey Branchini; Eliseo Guallar; Kathy J Helzlsouer; Thomas P Erlinger; Elizabeth A Platz
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

9.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

Authors:  Andre Franke; Tobias Balschun; Tom H Karlsen; Jurgita Sventoraityte; Susanna Nikolaus; Gabriele Mayr; Francisco S Domingues; Mario Albrecht; Michael Nothnagel; David Ellinghaus; Christian Sina; Clive M Onnie; Rinse K Weersma; Pieter C F Stokkers; Cisca Wijmenga; Maria Gazouli; David Strachan; Wendy L McArdle; Séverine Vermeire; Paul Rutgeerts; Philip Rosenstiel; Michael Krawczak; Morten H Vatn; Christopher G Mathew; Stefan Schreiber
Journal:  Nat Genet       Date:  2008-10-05       Impact factor: 38.330

10.  Leptin is a growth factor for colonic epithelial cells.

Authors:  J C Hardwick; G R Van Den Brink; G J Offerhaus; S J Van Deventer; M P Peppelenbosch
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

View more
  79 in total

Review 1.  IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review.

Authors:  Yong Yu; Wenjun Wang; Song Zhai; Shuangsuo Dang; Mingzhu Sun
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

Review 2.  TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis.

Authors:  Xu-Feng Guo; Jun Wang; Shi-Jie Yu; Jia Song; Meng-Yao Ji; Zhuo Cao; Ji-Xiang Zhang; Jing Wang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.

Authors:  Bingbing Wei; Zhuoqun Xu; Jun Ruan; Ming Zhu; Ke Jin; Deqi Zhou; Zhiqiang Yan; Feng Xuan; Hongyi Zhou; Xing Huang; Jian Zhang; Peng Lu; Jianfeng Shao
Journal:  Mol Biol Rep       Date:  2011-06-09       Impact factor: 2.316

4.  TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.

Authors:  Marcela Alcântara Proença; Juliana Garcia de Oliveira; Aline Cristina Targa Cadamuro; Maysa Succi; João Gomes Netinho; Eny Maria Goloni-Bertolo; Érika Cristina Pavarino; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Innate immunity gene polymorphisms and the risk of colorectal neoplasia.

Authors:  Cindy M Chang; Victoria M Chia; Marc J Gunter; Krista A Zanetti; Bríd M Ryan; Julie E Goodman; Curtis C Harris; Joel Weissfeld; Wen-Yi Huang; Stephen Chanock; Meredith Yeager; Richard B Hayes; Sonja I Berndt
Journal:  Carcinogenesis       Date:  2013-06-26       Impact factor: 4.944

Review 6.  Association of LEP A19G polymorphism with cancer risk: a systematic review and pooled analysis.

Authors:  Pengcheng Liu; Hui Shi; Changjia Huang; Hexi Shu; Run Liu; Yunji Yang; Jinpeng Gong; Yong Yang; Ming Cai
Journal:  Tumour Biol       Date:  2014-05-21

7.  Determination of the Relationship Between rs4986790 and rs4986791 Variants of TLR4 Gene and Lung Cancer.

Authors:  Hulyam Kurt; Cansu Ozbayer; Aysegul Bayramoglu; Hasan Veysi Gunes; İrfan Degirmenci; Kevser Setenay Oner; Muzaffer Metintas
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

8.  Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Authors:  Hansong Wang; Darin Taverna; Daniel O Stram; Barbara K Fortini; Iona Cheng; Lynne R Wilkens; Terrilea Burnett; Karen W Makar; Noralane M Lindor; John L Hopper; Steve Gallinger; John A Baron; Robert Haile; Laurence N Kolonel; Brian E Henderson; Polly A Newcomb; Graham Casey; David Duggan; Cornelia M Ulrich; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

9.  Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis.

Authors:  Hui-Jie Fan; Zheng-Fang Wen; Ben-Ling Xu; Jing-Jing Wu; Yong-Xu Jia; Ming Gao; Ming-Jun Li; Yan-Ru Qin
Journal:  Tumour Biol       Date:  2012-12-09

10.  Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.

Authors:  Katharine N Sourbeer; Lauren E Howard; Gerald L Andriole; Daniel M Moreira; Ramiro Castro-Santamaria; Stephen J Freedland; Adriana C Vidal
Journal:  BJU Int       Date:  2014-10-20       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.